ARTIVION INC (AORT) Stock Price & Overview

NYSE:AORT • US2289031005

Current stock price

34.16 USD
-2.46 (-6.72%)
At close:
34.16 USD
0 (0%)
After Hours:

The current stock price of AORT is 34.16 USD. Today AORT is down by -6.72%. In the past month the price decreased by -11.27%. In the past year, price increased by 47.11%.

AORT Key Statistics

52-Week Range21.97 - 48.25
Current AORT stock price positioned within its 52-week range.
1-Month Range33.77 - 38.41
Current AORT stock price positioned within its 1-month range.
Market Cap
1.636B
P/E
189.78
Fwd P/E
93.70
EPS (TTM)
0.18
Dividend Yield
N/A

AORT Stock Performance

Today
-6.72%
1 Week
-5.43%
1 Month
-11.27%
3 Months
-23.17%
Longer-term
6 Months -16.78%
1 Year +47.11%
2 Years +74.11%
3 Years +146.29%
5 Years N/A
10 Years N/A

AORT Stock Chart

ARTIVION INC / AORT Daily stock chart

AORT Technical Analysis

ChartMill assigns a technical rating of 1 / 10 to AORT. When comparing the yearly performance of all stocks, AORT turns out to be only a medium performer in the overall market: it outperformed 61.97% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

AORT Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to AORT. AORT has only an average score on both its financial health and profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

AORT Earnings

On February 12, 2026 AORT reported an EPS of 0.05 and a revenue of 115.99M. The company missed EPS expectations (-39.98% surprise) and missed revenue expectations (-2.32% surprise).

Next Earnings DateMay 4, 2026
Last Earnings DateFeb 12, 2026
PeriodQ4 / 2025
EPS Reported$0.05
Revenue Reported115.992M
EPS Surprise -39.98%
Revenue Surprise -2.32%

AORT Forecast & Estimates

13 analysts have analysed AORT and the average price target is 52.46 USD. This implies a price increase of 53.56% is expected in the next year compared to the current price of 34.16.

For the next year, analysts expect an EPS growth of 102.54% and a revenue growth 11.86% for AORT


Analysts
Analysts83.08
Price Target52.46 (53.57%)
EPS Next Y102.54%
Revenue Next Year11.86%

AORT Groups

Sector & Classification

AORT Financial Highlights

Over the last trailing twelve months AORT reported a non-GAAP Earnings per Share(EPS) of 0.18. The EPS increased by 141.86% compared to the year before.


Income Statements
Revenue(TTM)441.33M
Net Income(TTM)9.76M
Industry RankSector Rank
PM (TTM) 2.21%
ROA 1.1%
ROE 2.18%
Debt/Equity 0.49
Chartmill High Growth Momentum
EPS Q2Q%112.82%
Sales Q2Q%19.2%
EPS 1Y (TTM)141.86%
Revenue 1Y (TTM)13.59%

AORT Ownership

Ownership
Inst Owners88.38%
Shares47.88M
Float43.84M
Ins Owners4.23%
Short Float %3.82%
Short Ratio3.92

About AORT

Company Profile

AORT logo image Artivion, Inc. engages in the manufacture, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. The company is headquartered in Kennesaw, Georgia and currently employs 1,800 full-time employees. The firm is engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. The company has four major product families: aortic stent grafts, surgical sealants, On-X mechanical heart valves and related surgical products, and implantable cardiac and vascular human tissues. Its Medical Devices segment includes sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. Its Preservation Services segment includes services for the preservation of cardiac and vascular implantable human tissues. Aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Surgical sealants include its BioGlue Surgical Adhesive products.

Company Info

IPO: 1993-02-12

ARTIVION INC

1655 Roberts Boulevard N W

Kennesaw GEORGIA US

Employees: 1800

AORT Company Website

AORT Investor Relations

Phone: 17704193355

ARTIVION INC / AORT FAQ

Can you describe the business of ARTIVION INC?

Artivion, Inc. engages in the manufacture, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. The company is headquartered in Kennesaw, Georgia and currently employs 1,800 full-time employees. The firm is engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. The company has four major product families: aortic stent grafts, surgical sealants, On-X mechanical heart valves and related surgical products, and implantable cardiac and vascular human tissues. Its Medical Devices segment includes sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. Its Preservation Services segment includes services for the preservation of cardiac and vascular implantable human tissues. Aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Surgical sealants include its BioGlue Surgical Adhesive products.


What is the current price of AORT stock?

The current stock price of AORT is 34.16 USD. The price decreased by -6.72% in the last trading session.


Does AORT stock pay dividends?

AORT does not pay a dividend.


What is the ChartMill technical and fundamental rating of AORT stock?

AORT has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 5 out of 10.


Which stock exchange lists AORT stock?

AORT stock is listed on the New York Stock Exchange exchange.


Can you provide the number of employees for ARTIVION INC?

ARTIVION INC (AORT) currently has 1800 employees.


Can you provide the market cap for ARTIVION INC?

ARTIVION INC (AORT) has a market capitalization of 1.64B USD. This makes AORT a Small Cap stock.